Patent Category: Therapies

Use of epigenetic inhibitor 1-(β-D-ribofuranosyol)-2(1H)-pyrimidinone (zebularine) for promoting wound healing, complex tissue and organ regeneration

01.09.2020

In one aspect, the present invention provides a composition comprising zebularine, a nucleotide inhibitor of DNA methyltransferase, optionally in combination with retinoic acid, and said composition for use in promoting complex tissue regeneration and wound healing in a subject. In another aspect the present invention provides zebularine as a therapeutic agent, optionally in combination with retinoic acid, for use in promoting regeneration and healing of wounds resulting from mechanical ...

New peptide derivatives of platelet-derived growth factor (PDGF), method for obtaining, pharmaceutical composition and application

01.09.2020

The present invention relates to novel peptide derivatives of platelet derived growth factor (PDGF) and a method for their preparation. In addition, the invention relates to a pharmaceutical ...

Prion protein-dendrimer conjugates for use in the treatment of Alzheimer disease

01.09.2020

Oligomers of Aβ peptide are strong neurotoxins and their presence correlates with the progression of pathological changes in patients with Alzheimer's disease (AD), especially the so-called ...

Application of naringenin and naringenin-containing preparation, and method for slowing, counteracting and preventing the process of formation of albinotic spots on skin

01.09.2020

The patent application relates to the use of naringenin in an effective amount for slowing, counteracting and preventing the process offormation of albinotic spots on skin. The patent application ...

3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance

01.09.2020

A subject of the invention is a compound 3-dodecylsulfanyl-butyric acid for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance. The ...